Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 532474생성일: 2026년 10월 26일
Ammonium Hydroxide → 7-Bromo-4-[4-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-thieno[3,2-d]pyrimidine
https://huagongshe.com/reaction/532474
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Ammonium Hydroxide | HCID 14923 | — |
| 반응물 | Diisopropylethylamine | HCID 81531 | — |
| 반응물 | 7-Bromo-4-chlorothieno[3,2-d]pyrimidine | HCID 16655266 | — |
| 반응물 | 4-(3-(Propan-2-yl)-1,2,4-oxadiazol-5-yl)piperidine | HCID 24208845 | — |
| 용매 | Isopropanol | HCID 3776 | — |
| 생성물 | 7-Bromo-4-[4-(3-isopropyl-[1,2,4]oxadiazol-5-yl)-piperidin-1-yl]-thieno[3,2-d]pyrimidine | HCID 68299390 | 61.1% |
반응 단계
7-bromo-4-chlorothieno[3,2-d]pyrimidine (100 mg) was added to isopropyl alcohol (3 mL), and 4-(3-isopropyl-[1,2,4]-oxadiazol-5-yl)piperidine (100 mg) and diisopropylethylamine (200 μL) were further added thereto. The reaction mixture was stirred at 100° C. for 12 hours. Then, the reaction mixture was mixed with saturated ammonium hydroxide solution and extracted twice with ethyl acetate. The organic layer was washed with water, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure to obtain a foamy residue. The residue was crystallized in the presence of diethyl ether to obtain the title compound (100 mg) as a whitish solid.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US08853213B2 |
|---|
| 출처 데이터셋 | uspto-grants-2014_10 |
|---|
| ORD ID | ord-5eb4980247e24944baaa66c8fdd70aa6 |
|---|
| 출처 메모 | uspto-grants-2014_10 |
|---|